You are here

FTC

Pharma hopes Trump will bring change to the FTC. They may be disappointed.

BioPharma Dive

Mon, 12/2/24 - 07:39 pm

pharma industry

With Trump victorious, biotech industry’s focus turns to his plans for FDA, FTC

BioPharma Dive

Thu, 11/7/24 - 11:30 am

Robert F Kennedy Jr.

Why pharma megamergers may become a relic of the past

Pharma Voice

Thu, 10/24/24 - 09:49 am

Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal

Fierce Pharma

Fri, 10/18/24 - 11:26 am

CVS, UnitedHealth press for FTC Chair Khan to be removed from PBM lawsuit

The Hill

Wed, 10/9/24 - 09:09 pm

Express Scripts sues FTC over drug pricing report

Reuters

Tue, 09/17/24 - 11:01 am

Express Scripts

Patent thickets in federal government’s crosshairs as election 2024 looms

BioSpace

Wed, 08/28/24 - 11:57 am

patent thickets

2024 Presidential election

US judge strikes down Biden administration ban on worker 'noncompete' agreements

Reuters

Tue, 08/20/24 - 10:12 pm

noncompete agreements

Boston Scientific resubmits Silk Road merger filing, giving FTC more review time

Medtech Dive

Sun, 08/18/24 - 09:17 pm

Boston Scientific

Silk Road Medical

PBM Power: The Gross-to-Net Bubble Reached $334 Billion in 2023—But Will Soon Start Deflating

Drug Channels

Tue, 07/16/24 - 12:01 pm

FTC poised to sue drug middlemen over insulin prices

Axios

Fri, 07/12/24 - 11:30 am

Express Scripts

FTC report finds PBM power has “dire consequences”

Pharmaphorum

Tue, 07/9/24 - 11:22 am

FTC opens investigation into Teva, escalating patent fight with pharma industry

Washington Post, DC

Mon, 07/1/24 - 10:02 pm

Teva Pharmaceutical

FTC Supports PTO Push for Patent Settlement Scrutiny, Better Antitrust Oversight

BioSpace

Thu, 06/20/24 - 11:25 am

FTC backs rule change that could expose anticompetitive drug patent deals

First Word Pharma

Tue, 06/18/24 - 08:00 pm

FTC request may signal trouble for Novo/Catalent deal

Pharma Voice

Thu, 05/30/24 - 11:09 am

Maze lands new partner for Pompe drug, after Sanofi pact came apart

BioPharma Dive

Fri, 05/10/24 - 11:29 am

Maze Therapeutics

FTC seeks more information on Novo Nordisk parent-Catalent deal

Reuters

Fri, 05/3/24 - 11:28 am

GSK defends itself—again—after senator argues it withdrew popular asthma med to dodge price caps and Medicaid rebates

Fierce Pharma

Fri, 05/3/24 - 11:26 am

FTC crackdown on ‘bogus’ patents hits Novo’s Ozempic, GSK’s Trelegy Ellipta

Medical Marketing and Media

Fri, 05/3/24 - 11:10 am

Trelegy Ellipta

Pages